Drug Safety

, Volume 16, Issue 5, pp 309–329 | Cite as

Ketorolac for Postoperative Pain Management in Children

  • James B. Forrest
  • Ellen L. Heitlinger
  • Stephen Revell
Review Articles Drug Experience

Summary

Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) with potent analgesic effects and a relatively low incidence of adverse effects. Numerous clinical trials of postoperative pain treatment in children have shown that ketorolac is as effective as the major opioid analgesics, such as morphine, and more effective than codeine.

The pharmacokinetics of ketorolac differ in children compared with adult patients after surgery. In children, the volume of distribution (Vd) of ketorolac is increased by as much as 2-fold relative to that in adults. The plasma clearance (CL) of ketorolac is also higher in children, probably because of lower binding to plasma proteins. However, the elimination half-life (t½β) of ketorolac is similar in children and adults because t½β is directly proportional to Vd but inversely proportional to CL. These pharmacokinetic differences indicate that a higher relative dosage is required in children, but the dosage interval is similar in children and adults.

Ketorolac can be administered intravenously, intramuscularly or orally. The intravenous route is preferred during the immediate postoperative period, until the patient can tolerate oral medication. Intramuscular injections are not recommended in children, unless the intravenous route is unavailable. The recommended intravenous dosage of ketorolac in children is 0.5 mg/kg, followed either by bolus injections of 1.0 mg/kg every 6 hours or an intravenous infusion of 0.17 mg/kg/h. The maximum daily dosage is 90mg, and the maximum duration of treatment is 48 hours. The recommended oral dosage is 0.25 mg/kg to a maximum of 1.0 mg/kg/day, with a maximum duration of 7 days. Older children may require somewhat lower dosages, while infants and young children may require slightly higher dosages to achieve the same level of pain relief. Ketorolac is not recommended for use in infants aged <1 year.

Unlike opioid analgesics, ketorolac does not depress ventilation, and is not associated with nausea and vomiting, urinary retention or sedation. When combined with an opioid, ketorolac exhibits marked opioid-sparing effects, allowing a lower dosage of opioid to be used. Clinical studies in children and adults show that the synergistic action of ketorolac and opioids improves the degree and quality of pain relief, and reduces the incidence of opioid-related adverse effects such as respiratory depression, nausea/vomiting and ileus. Recovery of bowel function after abdominal surgery occurs sooner in ketorolac- compared with opioid-treated patients.

Ketorolac reversibly inhibits cyclo-oxygenase, and decreases the hypersensitisation of tissue nociceptors that occurs with surgery. It also has reversible antiplatelet effects, which are attributable to the inhibition of thromboxane synthesis. Bleeding time is usually slightly increased, but in most patients it remains within normal values. There is conflicting evidence of the potential for increased surgical-site bleeding after tonsillectomy but, for other types of paediatric surgery, numerous clinical studies have confirmed that ketorolac is not associated with increased bleeding. Thus, ketorolac is well suited for the treatment of postoperative pain in children, either alone or in combination with opioids or local anaesthetics, because of its analgesic potency and relatively low incidence of adverse effects.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Acute pain management in infants, children and adolescents: operative and medical procedures: clinical practice guideline. AHCPR publication no. 92–0032. Rockville (MD): Agency for Health Care Policy and Research, US Department of Health and Human Services, 1992Google Scholar
  2. 2.
    American Society of Anesthesiology. Practice guidelines for acute pain management in the perioperative setting. Anesthesiology 1995; 82: 1071–81Google Scholar
  3. 3.
    Burke JP, Pestotnik SL, Classen DC, et al. Evaluation of the financial impact of ketorolac tromethamine therapy in hospitalized patients. Clin Ther 1996; 18: 197–211PubMedGoogle Scholar
  4. 4.
    Stahlgren LR, Trierweiler M, Tommerassen M, et al. Comparison of ketorolac and meperidine in patients with postoperative pain — impact on health care utilization. Clin Ther 1993; 15: 571–80PubMedGoogle Scholar
  5. 5.
    Kehlet H. Surgical stress: the role of pain and analgesia. Br J Anaesth 1989; 63: 189–95PubMedGoogle Scholar
  6. 6.
    Lewis KS, Whipple JK, Michael KA, et al. Effect of analgesic treatment on the physiological consequences of acute pain. Am J Hosp Pharm 1994; 51: 1539–54PubMedGoogle Scholar
  7. 7.
    National Health and Medical Research Council (Australia). Management of severe pain. Canberra: National Health and Medical Research Council, 1988Google Scholar
  8. 8.
    American Pain Society. Principles of analgesic use in the treatment of acute pain and chronic cancer pain: a concise guide to medical practice. 2nd ed. Skokie (IL): American Pain Society, 1989Google Scholar
  9. 9.
    International Association for the Study of Pain (IASP), Ready LB, Edwards WT, editors. Management of acute pain: a practical guide. Seattle (WA): International Association for the Study of Pain Publications, 1992Google Scholar
  10. 10.
    Carpenter RL, Abram SE, Bromage PR, et al. Consensus statement on acute pain management. Reg Anesth 1996; 21: 152–6PubMedGoogle Scholar
  11. 11.
    Mather L, Mackie J. The incidence of postoperative pain in children. Pain 1983; 15: 271–82PubMedGoogle Scholar
  12. 12.
    Beyer JE, DeGood DE, Ashley LC. Patterns of postoperative analgesic use with adults and children following cardiac surgery. Pain 1983; 17: 71–81PubMedGoogle Scholar
  13. 13.
    Johnston CC, Abbott FV, Gray-Donald K, et al. A survey of pain in hospitalised patients aged 4–14 years. Clin J Pain 1992; 8: 154–63PubMedGoogle Scholar
  14. 14.
    Cummings EA, Reid GT, Finley GA, et al. Prevalence and source of pain in pediatric inpatients. Pain 1996; 68: 25–31PubMedGoogle Scholar
  15. 15.
    McGrath PA. Pain in children: nature, assessment, and treatment. New York: Guilford Press, 1990Google Scholar
  16. 16.
    Bush JP, Holmbeck GN, Cockrell JL. Patterns of PRN analgesic drug administration in children following elective surgery. J Pediatr Psychol 1989; 14: 433–48PubMedGoogle Scholar
  17. 17.
    Maunuksela E. Nonsteroidal anti-inflammatory drugs in pediatric pain management. In: Schechter NL, Berde CB, Yaster M, editors. Pain in infants and children. Baltimore (MD): Williams and Wilkins, 1993: 135–43Google Scholar
  18. 18.
    Treede RD, Meyer RA, Raja SN, et al. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 1992; 38: 397–421PubMedGoogle Scholar
  19. 19.
    Woolf CJ. A new strategy for the treatment of inflammatory pain: prevention or elimination of central sensitization. Drugs 1994; 47 Suppl. 5: 1–9PubMedGoogle Scholar
  20. 20.
    Forrest JB. Sympathetic mechanisms in postoperative pain. Can J Anaesth 1992; 39: 523–7PubMedGoogle Scholar
  21. 21.
    Buckley MMT, Brogden RN. Ketorolac: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 1990; 39: 86–109PubMedGoogle Scholar
  22. 22.
    Rooks WH, Maloney PJ, Schott LD, et al. The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt. Drugs Exp Clin Res 1985; 11: 479–92PubMedGoogle Scholar
  23. 23.
    Forrest JB. Clinical efficacy and safety of ketorolac tromethamine: a potent non-opioid analgesic. Todays Ther Trends 1992; 10: 129–50Google Scholar
  24. 24.
    Forrest JB. Nonsteroidal anti-inflammatory drugs (NSAIDs): have they altered practice parameters for pain management? In: Hines R, Bowdle A, editors. Annual of anesthesia pharmacology. Vol. I. Philadelphia: W.B. Saunders, 1996: 179–204Google Scholar
  25. 25.
    Brandon-Bravo LJC, Mattie H, Spierdijk J, et al. The effects on ventilation of ketorolac in comparison with morphine. Eur J Clin Pharmacol 1988; 35: 491–4Google Scholar
  26. 26.
    Watcha MF, Jones MB, Lagueruela RG, et al. Comparison of ketorolac and morphine as adjuvants during pediatric surgery. Anesthesiology 1992; 76: 368–72PubMedGoogle Scholar
  27. 27.
    Vane JR, Botting RM. Mechanisms of action of anti-inflammatory drugs. Scand J Rheumatol 1996; 25 Suppl. 102: 9–21Google Scholar
  28. 28.
    Mitchell JA, Akarasereenont P, Thiemermann C, et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci US A 1993; 90: 11693–7Google Scholar
  29. 29.
    Laneuville O, Breuer DK, DeWitt DL, et al. Differential inhibition of human prostaglandin endoperoxide H synthases -1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 1994; 271: 927–34PubMedGoogle Scholar
  30. 30.
    Carabaza A, Cabre F, Rotllan E, et al. Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugs. J Clin Pharmacol 1996; 36: 505–12PubMedGoogle Scholar
  31. 31.
    Smith WL, DeWitt DL. Prostaglandin endoperoxide H synthases -1 and -2. Adv Immunol 1996; 62: 167–215PubMedGoogle Scholar
  32. 32.
    Langman MJS, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994; 343: 1075–80PubMedGoogle Scholar
  33. 33.
    Forrest JB. Defining the role of nonsteroidal anti-inflammatory drugs (NSAIDs) in postoperative pain management. S Afr J Anaesth Analg 1996; 2: 8–13Google Scholar
  34. 34.
    Greer IA. Effects of ketorolac tromethamine on hemostasis. Pharmacotherapy 1990; 10 (6 Pt 2): 71S–6SPubMedGoogle Scholar
  35. 35.
    Dordoni PL, Delia Ventura M, Steffanelli A, et al. Effect of ketorolac, ketoprofen and nefopam on platelet function. Anaesthesia 1994; 49: 1046–9PubMedGoogle Scholar
  36. 36.
    Malmberg AB, Yaksh TL. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 1992; 257: 1276–9PubMedGoogle Scholar
  37. 37.
    McCormack K. Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain 1994; 59: 9–43PubMedGoogle Scholar
  38. 38.
    Resman-Targoff BH. Ketorolac: a parenteral nonsteroidal anti-inflammatory drug. Ann Pharmacother 1990; 24: 1098–104Google Scholar
  39. 39.
    Alexander JI, Hill RG. Postoperative pain control. Oxford: Blackwell Scientific Publications, 1987Google Scholar
  40. 40.
    Bhatt-Mehta V, Rosen DA. Management of acute pain in children. Clin Pharm 1991; 10: 667–85PubMedGoogle Scholar
  41. 41.
    Maunuksela E. Pain treatment in infants and children. Acta Anaesthesiol Scand 1991; 35 Suppl. 96: 157–9Google Scholar
  42. 42.
    Valley RD, Bailey AG. Caudal morphine for postoperative analgesia in infants and children: a report of 138 cases. Anesth Analg 1991; 72: 120–4PubMedGoogle Scholar
  43. 43.
    Olkkola KT, Hamunen K, Maunuksela EL. Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children. Clin Pharmacokinet 1995; 28: 385–404PubMedGoogle Scholar
  44. 44.
    Buck ML. Clinical experience with ketorolac in children. Ann Pharmacother 1994; 28: 1009–13PubMedGoogle Scholar
  45. 45.
    Maunuksela E, Kokki H, Bullingham RES. Comparison of intravenous ketorolac with morphine for postoperative pain in children. Clin Pharmacol Ther 1992; 52: 436–43PubMedGoogle Scholar
  46. 46.
    Gillies GWA, Kenny GNC, Bullingham RES, et al. The morphine sparing effect of ketorolac tromethamine. Anaesthesia 1987; 42: 727–31PubMedGoogle Scholar
  47. 47.
    Vetter TR, Heiner EJ. Intravenous ketorolac as an adjuvant to pediatric patient-controlled analgesia with morphine. J Clin Anesth 1994; 6: 110–3PubMedGoogle Scholar
  48. 48.
    Richter RL, Valley RD, Bailley AG, et al. A comparison of intraoperative ketorolac, morphine and saline on postoperative analgesia in the pediatric patient [abstract]. Anesthesiology 1992; 77: A1161Google Scholar
  49. 49.
    Tesler MD, Wilkie DJ, Holzerner WL, et al. Postoperative analgesics for children and adolescents: prescription and administration. J Pain Symptom Manage 1994; 9: 85–95PubMedGoogle Scholar
  50. 50.
    Kehlet H. Synergism between analgesics. Ann Med 1995; 27: 259–62PubMedGoogle Scholar
  51. 51.
    Jung D, Mroszczak E, Bynum L. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration. Eur J Clin Pharmacol 1988; 35: 423–5PubMedGoogle Scholar
  52. 52.
    Olkkola KT, Maunuksela EL. The pharmacokinetics of postoperative intravenous ketorolac tromethamine in children. Br J Clin Pharmacol 1991; 31: 182–4PubMedGoogle Scholar
  53. 53.
    Brocks DR, Jamali F. Clinical pharmacokinetics of ketorolac tromethamine. Clin Pharmacokinet 1992; 23: 415–27PubMedGoogle Scholar
  54. 54.
    Jallad NS, Garg DC, Martinez JJ, et al. Pharmacokinetics of single-dose oral and intramuscular ketorolac tromethamine in the young and elderly. J Clin Pharmacol 1990; 30: 76–81PubMedGoogle Scholar
  55. 55.
    Cohen DE, Siegal S, Davis L, et al. Pharmacokinetics of intravenous ketorolac in infants less than 1 year of age [abstract]. Anesthesiology 1994; 81: A1334Google Scholar
  56. 56.
    Lieh-Lai M, Kauffman R, Uy H, et al. Pharmacokinetics of intravenous ketorolac tromethamine in critically-ill children |abstract|. Crit Care Med 1995; 23: A219Google Scholar
  57. 57.
    Kerr KA, Banner W, Pappas J, et al. A pharmacokinetic study comparing intermittent vs continuous infusion ketorolac in a pediatric intensive care unit (PICU) [abstract]. Crit Care Med 1994; 22: A182Google Scholar
  58. 58.
    Houck CS, Wilder RT, McDermott JS, et al. Safety of intravenous ketorolac therapy in children and cost savings with a unit dosing system. J Pediatr 1996; 129: 292–6PubMedGoogle Scholar
  59. 59.
    Bean-Lijewski JD, Hunt RD. Effect of ketorolac on bleeding time and postoperative pain in children: a double-blind, placebo-controlled comparison with meperidine. J Clin Anesth 1996; 8: 25–30PubMedGoogle Scholar
  60. 60.
    Brock BM, Custer MD, Bean-Lijewski JD. Ketorolac vs wound infiltration: a prospective comparison |abstract|. Anesth Analg 1995; 80: S55Google Scholar
  61. 61.
    Poinier AC, Jacobson LE, Geiduschek J, et al. A comparison of ketorolac to other modalities for pain relief after inguinal herniorrhaphy in children [abstract]. J Clin Invest Med 1996; 44: 150Google Scholar
  62. 62.
    Cohen IT, Latta K, Wiener ES, et al. A study of ketorolac for intraoperative and postoperative analgesia for herniorrhaphy in children |abstract|. Anesth Analg 1993; 76: S50Google Scholar
  63. 63.
    Graham SG, Wandless JG. The effect of ketorolac as an adjuvant to local anaesthetic infiltration for analgesia in paediatric umbilical hernia surgery. Paediatr Anaesth 1995; 5: 161–3PubMedGoogle Scholar
  64. 64.
    Stinson J, Bean JD. A comparison of prophylactic oral ketorolac and acetaminophen for post-BMT pain in children |abstract|. Anesthesiology 1994; 81: A1360Google Scholar
  65. 65.
    Watcha MF, Ramirez-Ruiz M, White PF, et al. Perioperative effects of oral ketorolac and acetaminophen in children undergoing bilateral myringotomy. Can J Anaesth 1992; 39: 649–54PubMedGoogle Scholar
  66. 66.
    Mendel HG, Guarnieri KM, Sundt LM, et al. The effects of ketorolac and fentanyl on postoperative vomiting and analgesic requirements in children undergoing strabismus surgery. Anesth Analg 1995; 80: 1129–33PubMedGoogle Scholar
  67. 67.
    Munro HM, Riegger LQ, Reynolds PI, et al. Comparison of the analgesic and emetic properties of ketorolac and morphine for paediatric outpatient strabismus surgery. Br J Anaesth 1994; 72: 624–8PubMedGoogle Scholar
  68. 68.
    Gevirtz CM, Whitten C. A comparison of ketorolac and morphine for postoperative analgesia in cleft lip and palate surgery |abstract no. 245|. Proceedings of the 10th World Congress on Anaesthesiology: 1992 Jun 12–19; The Hague, The NetherlandsGoogle Scholar
  69. 69.
    Prego G, Moscovici R, Schwartz M. Postoperative analgesia in children after odontologie procedures: a comparison of diclofenac versus ketorolac in the outpatient clinic |abstract|. Br J Anaesth 1994; 72 Suppl. 1: 95Google Scholar
  70. 70.
    Purday JP, Reichert CC, Merrick P. Ketorolac: a paediatric intravenous dose finding study |abstract|. Can J Anaesth 1993; 40: A65Google Scholar
  71. 71.
    Carithers JS, Gebhart DE, Williams JA. Postoperative risks of pediatric tonsilloadenoidectomy. Laryngoscope 1987; 97: 422–9PubMedGoogle Scholar
  72. 72.
    Handler SD, Miler L, Richmond KH. Post-tonsillectomy hemorrhage: incidence, prevention and management. Laryngoscope 1986; 96: 1243–7PubMedGoogle Scholar
  73. 73.
    Reiner SA, Sawyer WP, Clark KF, et al. Safety of outpatient tonsillectomy and adenoidectomy. Otolaryngol Head Neck Surg 1990; 102: 161–8PubMedGoogle Scholar
  74. 74.
    Sutters KA, Levine JD, Dibble S, et al. Analgesic efficacy and safety of single-dose intramuscular ketorolac for postoperative pain management in children following tonsillectomy. Pain 1995; 61: 145–53PubMedGoogle Scholar
  75. 75.
    Gunter JB, Varughese AM, Harrington JF, et al. Recovery and complications after tonsillectomy in children: a comparison of ketorolac and morphine. Anesth Analg 1995; 81: 1136–41PubMedGoogle Scholar
  76. 76.
    Desparmet JF, MacArthur C, MacArthur A, et al. Pain and vomiting after tonsillectomy in children: a comparison of intraoperative ketorolac and fentanyl [abstract]. Anesthesiology 1993; 79: A1194Google Scholar
  77. 77.
    Fitz-James I, Ho J, Pang LM, et al. Effect of ketorolac on perioperative bleeding and analgesia in pediatric tonsillectomy and adenoidectomy patients |abstract|. Anesth Analg 1995; 80: S127Google Scholar
  78. 78.
    Mather SJ, Peutrell JM. Postoperative morphine requirements, nausea and vomiting following anaesthesia for tonsillectomy: comparison of intravenous morphine and non-opioid analgesic techniques. Paediatr Anaesth 1995; 5: 185–8PubMedGoogle Scholar
  79. 79.
    Rusy LM, Houck CS, Sullivan LJ, et al. A double-blind evaluation of ketorolac tromethamine versus acetaminophen in pediatric tonsillectomy: analgesia and bleeding. Anesth Analg 1995; 80: 226–9PubMedGoogle Scholar
  80. 80.
    Gallagher JE, Blauth J, Fornadley JA. Perioperative ketorolac tromethamine and postoperative hemorrhage in cases of tonsillectomy and adenoidectomy. Laryngoscope 1995; 105: 606–9PubMedGoogle Scholar
  81. 81.
    Hall SC. Tonsillectomies, ketorolac, and the march of progress. Can J Anaesth 1996; 43: 544–8PubMedGoogle Scholar
  82. 82.
    Splinter WM, Rhine EJ, Roberts DW, et al. Preoperative ketorolac increases bleeding after tonsillectomy in children. Can J Anaesth 1996; 43: 560–3PubMedGoogle Scholar
  83. 83.
    Judkins JH, Dray TG, Hubbell RN. Intraoperative ketorolac and posttonsillectomy bleeding. Arch Otolaryngol Head Neck Surg 1996; 122: 937–40PubMedGoogle Scholar
  84. 84.
    Strom BL, Berlin JA, Kinman JL, et al. Parenteral ketorolac and the risk of gastrointestinal and operative site bleeding: a postmarketing surveillance study. JAMA 1996; 275: 376–82PubMedGoogle Scholar
  85. 85.
    Strom BL, Berlin JA, Kinman JL, et al. Risk of operative site bleeding with parenteral ketorolac [letter]. JAMA 1996; 276: 372Google Scholar
  86. 86.
    Spiess BD. Coagulation functions in the operating room: hematologic disorders. Anesthesiol Clin North Am 1990; 13: 481–99Google Scholar
  87. 87.
    DeCaterina R, Lanza M, Manca G, et al. Bleeding time and bleeding: an analysis of the relationship of bleeding time test with parameters of surgical bleeding. Blood 1994; 84: 3363–70Google Scholar
  88. 88.
    Rodgers RPC, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990; 16: 1–20PubMedGoogle Scholar
  89. 89.
    Arcelus JI, Traverso CI, Caprini JA. Thromboelastography for the assessment of hypercoagulability during general surgery. Semin Thromb Hemost 1995; 21 Suppl. 4: 21–6PubMedGoogle Scholar
  90. 90.
    Gibbs NM, Sear JW. Effect of ketorolac, bupivacaine and low-dose heparin on thromboelastographic variables in vitro. Br J Anaesth 1995; 75: 27–30PubMedGoogle Scholar
  91. 91.
    Reinhart DJ, Latson TW, Whitten CW, et al. Influence of ketorolac tromethamine on clot elastic strength in humans as assessed by thromboelastography. J Clin Anesth 1993; 5: 216–20PubMedGoogle Scholar
  92. 92.
    Murphy WG, Davies MJ, Eduardo A. The haemostatic response to surgery and trauma. Br J Anaesth 1993; 70: 205–13PubMedGoogle Scholar
  93. 93.
    Lerman J, Eustis S, Smith DR. Effect of droperidol pretreatment on post-anesthetic vomiting in children undergoing strabismus surgery. Anesthesiology 1986; 65: 322–5PubMedGoogle Scholar
  94. 94.
    Riegger LQ, Munro HM, Reynolds PI, et al. A comparison of ketorolac and morphine in pediatric outpatient strabismus surgery |abstract|. Anesthesiology 1993; 79: A1179Google Scholar
  95. 95.
    Morrison NA, Repka MX. Ketorolac versus acetaminophen or ibuprofen in controlling postoperative pain in patients with strabismus. Ophthalmology 1994; 101: 915–8PubMedGoogle Scholar
  96. 96.
    Engesaeter LB, Sudmann B, Sudmann E, et al. Fracture healing in rats inhibited by locally administered indomethacin. Acta Orthop Scand 1992; 63: 330–3PubMedGoogle Scholar
  97. 97.
    Altman RD, Latta LL, Keer R, et al. Effect of nonsteroidal antiinflammatory drugs on fracture healing: a laboratory study in rats. J Orthop Trauma 1995; 9: 392–400PubMedGoogle Scholar
  98. 98.
    Obeid G, Zhang X, Wang X. Effect of ibuprofen on the healing and remodelling of bone and articular cartilage in the rabbit temporomandibular joint. J Oral Maxillofac Surg 1992; 50: 843–9PubMedGoogle Scholar
  99. 99.
    Ho ML, Chang JK, Wang GJ. Antiinflammatory drug effects on bone repair and remodelling in rabbits. Clin Orthop 1995; 313: 270–8PubMedGoogle Scholar
  100. 100.
    Huo MH, Troiano NW, Pelker RR, et al. The influence of ibuprofen on fracture repair: biomechanical, biochemical, histologie, and histomorphometric parameters in rats. J Orthop Res 1991; 9: 383–90PubMedGoogle Scholar
  101. 101.
    Mbugua SW, Skoglund LA, Lokken P. Effects of phenylbutazone and indomethacin on the post-operative course following experimental orthopedic surgery in dogs. Acta Vet Scand 1989; 30: 27–35PubMedGoogle Scholar
  102. 102.
    More RC, Kody MH, Kabo JM, et al. The effects of two nonsteroidal antiinflammatory drugs on limb swelling, joint stiffness, and bone torsional strength following fracture in a rabbit model. Clin Orthop 1989; 247: 306–12PubMedGoogle Scholar
  103. 103.
    Chez MG, Soglin D. Ketorolac tromethamine (Toradol) treatment in children with acute migraine |abstract|. Ann Neurol 1991; 30: 494Google Scholar
  104. 104.
    Shorrock CJ, Rees WDW. Mechanisms of gastric damage by non-steroidal anti-inflammatory drugs. Scand J Rheumatol Suppl 1989; 78: 5–11PubMedGoogle Scholar
  105. 105.
    Kenny GNC. Potential renal, haematological and allergic adverse effects associated with nonsteroidal anti-inflammatory drugs. Drugs 1992; 44 Suppl. 5: 31–7PubMedGoogle Scholar
  106. 106.
    Conrad KA, Fragan TC, Mackie MJ, et al. Effects of ketorolac tromethamine on hemostasis in volunteers. Clin Pharmacol Ther 1988; 43: 542–6PubMedGoogle Scholar
  107. 107.
    Thwaites BK, Nigus DB, Bouska GW, et al. Intravenous ketorolac tromethamine does not worsen platelet function during knee arthroscopy under general anesthesia. Anesth Analg 1995; 81: 119–24PubMedGoogle Scholar
  108. 108.
    Thwaites BK, Nigus DB, Bouska GW, et al. Intravenous ketorolac tromethamine worsens platelet function during knee arthoscopy under spinal anesthesia. Anesth Analg 1996; 82: 1176–81PubMedGoogle Scholar
  109. 109.
    Harris K. The role of prostaglandins in the control of renal function. Br J Anaesth 1992; 69: 233–5PubMedGoogle Scholar
  110. 110.
    Murray MD, Brater DC. Adverse effects of nonsteroidal anti-inflammatory drugs on renal function. Ann Intern Med 1990; 112: 559–60PubMedGoogle Scholar
  111. 111.
    Buck ML, Norwood VF. Ketorolac-induced acute renal failure in a previously healthy adolescent. Pediatrics 1996; 98: 294–6PubMedGoogle Scholar
  112. 112.
    Johnson AG, Seideman P, Day RO. Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs): recognition, management and avoidance. Drug Saf 1993; 8 (2): 99–127PubMedGoogle Scholar
  113. 113.
    Ferraz AAB, Cowles VE, Condon RE, et al. Nonopioid analgesics shorten the duration of postoperative ileus. Am Surg 1995; 61: 1079–83PubMedGoogle Scholar

Copyright information

© Adis International Limited 1997

Authors and Affiliations

  • James B. Forrest
    • 1
  • Ellen L. Heitlinger
    • 2
  • Stephen Revell
    • 3
  1. 1.McMaster University Medical CentreHamiltonCanada
  2. 2.Pharma Business DevelopmentF. Hoffmann-La Roche LtdBaselSwitzerland
  3. 3.Drug SafetyF. Hoffmann-La Roche LtdBaselSwitzerland

Personalised recommendations